EUVIMEDEUVIMED entdecken
Crossref

Renoprotective effects of synthetic bilirubin nanomedicine against ischemia-reperfusion injury after kidney transplantation

Ji-Jing Yan, Honglin Piao, Joon Young Jang, Bomin Kim, Hwan Lee, Minhee Seong, Kyu-Hyun Han, Minho Choi, Seunghyun Jo, Hee Byung Koh, Beom Seok Kim, Yoon-Seok Chang und 3 weitere

Clinical Science · 13.05.2026 · 140 (5) · 845-857

DOI: 10.1042/cs20250982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 06.05.2026. Verfasst von Ji-Jing Yan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Reperfusion Injury, Kidney Transplantation, Bilirubin, Kidney. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministry of Health and Welfare (MOHW).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal ischemia-reperfusion injury (IRI) poses a significant challenge in kidney transplantation, contributing to acute kidney injury and chronic kidney fibrosis. In the present study, we investigated renoprotective effects of BX-001N, a synthetic polyethylene glycol-conjugated bilirubin nanoparticle, against renal IRI after kidney transplantation. A murine syngeneic kidney transplantation model was used to study renal IRI. BX-001N was administered intravenously at 0 and 2.5 h post-transplantation. Renal functions (creatinine and BUN), histopathological injury, oxidative stress, renal regeneration, and fibrotic changes were assessed at post-transplant day (POD) 1 and 7. BX-001N significantly improved renal function and attenuated renal tissue injury and tubular cell apoptosis at POD 1, following cold IRI. It markedly reduced neutrophil infiltration and suppressed the expression of pro-inflammatory cytokines (TNF-α and IFN-γ) and chemokines (MCP-1 and CXCL2). Antioxidant responses were enhanced, as evidenced by increased expression of heme oxygenase-1 and decreased accumulation of nitrotyrosine. Furthermore, at POD 7, BX-001N promoted renal regeneration with increased Ki-67 and vascular endothelial growth factor expression. It also inhibited renal fibrosis and suppressed epithelial-mesenchymal transition with decreased expression of α-smooth muscle actin, while preserving E-cadherin expression. In conclusion, BX-001N effectively mitigates IRI-induced renal injury by reducing oxidative stress, inflammation, and fibrosis, indicating its potential therapeutic value in kidney transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryKidney TransplantationBilirubinKidneyNanoparticlesAnimalsOxidative StressMaleFibrosisMiceMice, Inbred C57BLApoptosisCytokinesAntioxidantsEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

bilirubin nanoparticleischaemia-reperfusion injurykidney transplantationreactive oxygen species

Substanzen

BilirubinCytokinesAntioxidants

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Department of Internal Medicine, Seoul National Universit-y Bundang Hospital, Seongnam 13620, Republic of Korea.
  • Department of Medicine, Graduate School, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • BILIX Co., Ltd., Yongin, Gyeonggi-do 16942, Republic of Korea.
  • Department of Biological Sciences, KAIST Institute for the BioCentury, Daejeon, Republic of Korea.
  • Center for Precision Bio-Nanomedicine, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.

ORCID-Profile: Jaeseok Yang

Förderung

  • Ministry of Health and Welfare (MOHW)

Zitieren

APA

Yan, J. J., Piao, H., Jang, J. Y., Kim, B., Lee, H., Seong, M., Han, K. H., Choi, M., Jo, S., Koh, H. B., Kim, B. S., Chang, Y. S., Jon, S., Kim, M. L., & Yang, J. (2026). Renoprotective effects of synthetic bilirubin nanomedicine against ischemia-reperfusion injury after kidney transplantation. Clinical Science, 140(5), 845-857. https://doi.org/10.1042/cs20250982

Vancouver

Yan JJ, Piao H, Jang JY, Kim B, Lee H, Seong M, et al. Renoprotective effects of synthetic bilirubin nanomedicine against ischemia-reperfusion injury after kidney transplantation. Clinical Science. 2026;140(5):845-857. doi:10.1042/cs20250982

BibTeX
@article{Yan2026,
  author = {Yan, Ji-Jing and Piao, Honglin and Jang, Joon Young and Kim, Bomin and Lee, Hwan and Seong, Minhee and Han, Kyu-Hyun and Choi, Minho and Jo, Seunghyun and Koh, Hee Byung and Kim, Beom Seok and Chang, Yoon-Seok and Jon, Sangyong and Kim, Myung L and Yang, Jaeseok},
  title = {Renoprotective effects of synthetic bilirubin nanomedicine against ischemia-reperfusion injury after kidney transplantation},
  journal = {Clinical Science},
  year = {2026},
  volume = {140},
  number = {5},
  pages = {845--857},
  doi = {10.1042/cs20250982}
}
Kostenlos starten →